Instil Bio Inc (TIL) — Who Owns This Stock? 13F Breakdown (Q2 2026)

TIL ranks #7896 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

TIL is a disclosed holding of Israel Englander (Millennium Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

25 institutions disclose a position in TIL, but none treat it as a major bet — even BML Capital Management, LLC, its most concentrated holder, allocates just 2.8% of its own portfolio to it.

UBS Group AG has added to its TIL position for two straight quarters, increasing it by $1.4M to reach $1.4M today.

BML Capital Management, LLC has trimmed its TIL position for two straight quarters, cutting it by $2.1M while still holding $5.0M.

TIL reported a net loss of $30.3M over the trailing twelve months.

• Not yet profitable — net loss of $30.3M over the trailing twelve months
• Revenue declined 100.0% year over year
• Net income improved year over year, from -$84.5M to -$30.3M
• Operating cash flow was negative, using $36.6M in cash
• Current ratio of 39.53x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.79x equity — within a conventional range